跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VACOPAN INJECTION 20 mg/ml - HSA Drug Approval Details
Approvals
/
HSA
/
VACOPAN INJECTION 20 mg/ml
Approved
THERAPEUTIC
VACOPAN INJECTION 20 mg/ml
ATLANTIC LABORATORIES CORPN LTD
🇸🇬 Health Sciences Authority
Approval Date
Nov 25, 1997
Approval ID
a710a397f96327f6
Company
ATLANTIC LABORATORIES CORPN LTD
Type
Therapeutic
Approval Details
Approval Id
a710a397f96327f6
Drug Name
VACOPAN INJECTION 20 mg/ml
Product Name
VACOPAN INJECTION 20 mg/ml
Approval Number
SIN09563P
Approval Date
1997-11-25
Registrant
ATLANTIC PHARMACEUTICAL (S) PTE LTD
Licence Holder
ATLANTIC PHARMACEUTICAL (S) PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION
Route Of Administration
INTRAVENOUS, SUBCUTANEOUS, INTRAMUSCULAR
Atc Code
A03BB01
Atc Item Name
butylscopolamine
Pharma Manufacturer Name
atlantic pharmaceutical (s) pte ltd
Active Ingredients
HYOSCINE N-BUTYLBROMIDE
20 mg/ml
HYOSCINE N-BUTYLBROMIDE
20 mg/ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Nov 25, 1997
Approval ID
a710a397f96327f6
Type
Therapeutic
Back to HSA Approvals